Safety of TKI258 in Advanced/Metastatic Melanoma Subjects
Clinical trial NCT00303251 · COMPLETED
Trial details
- NCT number
- NCT00303251
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2009-09-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.